Free Newsletter
Robotic IV compounding comes to UMass
Hazardous IV prep is becoming an automated process at the UMass Memorial Medical Center in Massachusetts. The hospital is using the CytoCare robot from healthcare services provider and drug wholesaler McKesson to automate the compounding of intravenous drugs.
The robotic system lessons staff exposure to toxic agents in the hospital pharmacy, which handles about 5,000 IV products per month. That compounding load was spread across 11 pharmacists, says a release.
CytoCare boasts HL7 interfaces. And it has a continuous production flow feature that aids in planning sterile-prep schedules and in complying with quality and safety regulations.
- see the UMass release
- here's a video
Related Article:
McKesson eyes automation for distribution center
More stories about McKesson
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: